2m 2m 2m 2m 2m 2m 2m
Harrow (HROW)
NASDAQ
$42.85+$0.06 (+0.15%)
Price as of Jun 23, 2026 7:14 PM EDT- $1.6BMarket Cap
- 36.81%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Harrow (HROW)
$42.85+$0.06 (+0.15%)
HROW | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $42.78 | ||
Change | -$0.46 (-1.07%) | ||
Open | $42.16 | ||
High | $43.58 | ||
Low | $41.89 | ||
Previous Close | $42.41 | ||
Volume | 1,299,396 | ||
30-Day Average Volume | 794,417 | ||
1-Week Change | 8.94% | ||
1-Month Change | 28.52% | ||
1-Year Change | 36.81% | ||
3-Year Change | 129.00% | ||
5-Year Change | 355.53% | ||
Fundamentals | |||
Shares Outstanding | 37.3M | ||
Total Assets | $419.5M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$9.2M | ||
EBIT | $25,000.00 | ||
EBITDA | $480,000.00 | ||
Net Working Capital | $134.9M | ||
EPS | -$0.74 | ||
Enterprise Value/EBITDA | 3,705 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 55 | ||
P/E | -57 | ||
PEG | N/A | ||
Price/Free Cash Flow | -172 | ||
Price/Operating Cash Flow | -176 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 02/08/2013 | ||
Earnings & Revenue